Cite
HARVARD Citation
Zheng, S. et al. (2018). A B7‐CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma. International journal of cancer. 143 (10), pp. 2592-2601. [Online].